Relapsed Peripheral T-Cell Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB05015 | Belinostat | A histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). |
DB06813 | Pralatrexate | An antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08870 | Brentuximab vedotin | 2 | Completed | 1 |
DB00115 | Cyanocobalamin | 2 | Completed | 1 |
DB00158 | Folic acid | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB18057 | Golidocitinib | 2 | Active Not Recruiting | 1 |
DB00650 | Leucovorin | 2 | Completed | 1 |
DB09074 | Olaparib | 2 | Not Yet Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Not Yet Recruiting | 1 |
DB06813 | Pralatrexate | 2 | Completed | 1 |
DB06334 | Tucidinostat | 2 | Recruiting | 1 |
DB05220 | Alisertib | 3 | Completed | 1 |
DB00441 | Gemcitabine | 3 | Completed | 1 |
DB06813 | Pralatrexate | 3 | Completed | 1 |
DB06176 | Romidepsin | 3 | Completed | 1 |